Natural killer cell memory

Nature Immunology

Volumn 12, Issue 6, 2011, Pages 500-508

  Paust, Silke ^a,b   Von Andrian, Ulrich H ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; IMMUNOLOGICAL MEMORY; IMMUNOSURVEILLANCE; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL;

EID: 79956151449     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2032     Document Type: Review

References (107)

1. Bassing, C.H., Swat, W. & Alt, F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109, S45-S55 (2002).
2. Phanuphak, P., Moorhead, J.W. & Claman, H.N. Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J. Immunol. 112, 849-851 (1974).
3. Phanuphak, P., Moorhead, J.W. & Claman, H.N. Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J. Immunol. 112, 115-123 (1974).
4. Crowle, A.J. Delayed hypersensitivity in mice; its detection by skin tests and its passive transfer. Science 130, 159-160 (1959).
5. Quan, F.S., Huang, C., Compans, R.W. & Kang, S.M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 81, 3514-3524 (2007). (Pubitemid 46456660)
6. Herberman, R.B., Nunn, M.E. & Lavrin, D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16, 216-229 (1975).
7. Herberman, R.B., Nunn, M.E., Holden, H.T. & Lavrin, D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 16, 230-239 (1975).
8. Lanier, L.L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005). (Pubitemid 40563170)
9. Walzer, T., Dalod, M., Robbins, S.H., Zitvogel, L. & Vivier, E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106, 2252-2258 (2005). (Pubitemid 41510793)
10. Orange, J.S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6, 399-409 (2006). (Pubitemid 44714151)
11. O'Leary, J.G., Goodarzi, M., Drayton, D.L. & von Andrian, U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7, 507-516 (2006).
12. Paust, S., Senman, B. & von Andrian, U.H. Adaptive immune responses mediated by natural killer cells. Immunol. Rev. 235, 286-296 (2010).
13. Sun, J.C., Beilke, J.N. & Lanier, L.L. Adaptive immune features of natural killer cells. Nature 457, 557-561 (2009).
14. Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127-1135 (2010).
15. Askenase, P.W. Yes T cells, but three different T cells (αβ, γδ and NK T cells), and also B-1 cells mediate contact sensitivity. Clin. Exp. Immunol. 125, 345-350 (2001). (Pubitemid 34155429)
16. Gorbachev, A.V. & Fairchild, R.L. Induction and regulation of T-cell priming for contact hypersensitivity. Crit. Rev. Immunol. 21, 451-472 (2001). (Pubitemid 34259915)
17. Boehncke, W.H. et al. Leukocyte extravasation as a target for anti-inflammatory therapy-which molecule to choose? Exp. Dermatol. 14, 70-80 (2005).
18. Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2, 223-238 (1995).
19. DiSanto, J.P., Muller, W., Guy-Grand, D., Fischer, A. & Rajewsky, K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA92, 377-381 (1995).
20. MacDougall, J.R., Croy, B.A., Chapeau, C. & Clark, D.A. Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG. Cell. Immunol. 130, 106-117 (1990). (Pubitemid 20329269)
21. Vermijlen, D. et al. High-density oligonucleotide array analysis reveals extensive differences between freshly isolated blood and hepatic natural killer cells. Eur. J. Immunol. 34, 2529-2540 (2004). (Pubitemid 39302810)
22. Ochi, M. et al. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39, 1321-1331 (2004). (Pubitemid 38569054)
23. Ishiyama, K. et al. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 43, 362-372 (2006).
24. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005). (Pubitemid 41117274)
25. Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA99, 8826-8831 (2002). (Pubitemid 34693643)
26. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002). (Pubitemid 34522789)
27. Cooper, M.A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA106, 1915-1919 (2009).
28. Zhang, X., Sun, S., Hwang, I., Tough, D.F. & Sprent, J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591-599 (1998). (Pubitemid 28264750)
29. Sallusto, F. & Lanzavecchia, A. Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity. Eur. J. Immunol. 39, 2076-2082 (2009).
30. Alvarez, D., Vollmann, E.H. & von Andrian, U.H. Mechanisms and consequences of dendritic cell migration. Immunity 29, 325-342 (2008).
31. Catalina, M.D. et al. The route of antigen entry determines the requirement for L-selectin during immune responses. J. Exp. Med. 184, 2341-2351 (1996). (Pubitemid 27023733)
32. Bajenoff, M. et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203, 619-631 (2006).
33. Jenne, C.N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
34. Morris, M.A. & Ley, K. Trafficking of natural killer cells. Curr. Mol. Med. 4, 431-438 (2004). (Pubitemid 38787011)
35. Geissmann, F. et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113 (2005).
36. Hunger, R.E., Yawalkar, N., Braathen, L.R. & Brand, C.U. The HECA-452 epitope is highly expressed on lymph cells derived from human skin. Br. J. Dermatol. 141, 565-569 (1999). (Pubitemid 29448428)
37. Carbone, T. et al. CD56highCD16?CD62L? NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J. Immunol. 184, 1102-1110 (2010).
38. Weninger, W. et al. Specialized contributions by α(1,3)- fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 12, 665-676 (2000).
39. Buentke, E. et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J. Invest. Dermatol. 119, 850-857 (2002). (Pubitemid 35340910)
40. van der Voort, R. et al. An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J. Leukoc. Biol. 87, 1029-1039 (2010).
41. Calabresi, P.A., Yun, S.H., Allie, R. & Whartenby, K.A. Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNγ-producing effector cells. J. Neuroimmunol. 127, 96-105 (2002). (Pubitemid 34603579)
42. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003). (Pubitemid 37328656)
43. Ferlazzo, G. et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33, 306-313 (2003). (Pubitemid 36267594)
44. Jinushi, M. et al. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 120, 73-82 (2007). (Pubitemid 44950472)
45. Nocentini, G., Ronchetti, S., Cuzzocrea, S. & Riccardi, C. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur. J. Immunol. 37, 1165-1169 (2007). (Pubitemid 46925300)
46. H1 priming. Nat. Immunol. 5, 1260-1265 (2004). (Pubitemid 41057741)
47. Gao, N., Dang, T. & Yuan, D. IFN-gamma-dependent and -independent initiation of switch recombination by NK cells. J. Immunol. 167, 2011-2018 (2001). (Pubitemid 32747508)
48. Lunemann, A., Lunemann, J.D. & Munz, C. Regulatory NK-cell functions in inflammation and autoimmunity. Mol. Med. 15, 352-358 (2009).
49. Namekawa, T. et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165, 1138-1145 (2000). (Pubitemid 30484786)
50. Martin, M.P. et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169, 2818-2822 (2002). (Pubitemid 35013118)
51. Momot, T. et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 50, 1561-1565 (2004). (Pubitemid 38608078)
52. Suzuki, Y. et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 122, 1133-1136 (2004). (Pubitemid 38651087)
53. Hedman, M., Faresjo, M., Axelsson, S., Ludvigsson, J. & Casas, R. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children. Clin. Exp. Immunol. 153, 360-368 (2008).
54. Kim, J.V. et al. Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites. J. Immunol. Methods 352, 89-100 (2009).
55. Ivakine, E.A. et al. Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice. J. Immunol. 176, 2976-2990 (2006).
56. Garcia, G.E. et al. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am. J. Pathol. 170, 1485-1496 (2007). (Pubitemid 47339295)
57. Sordi, V. et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106, 419-427 (2005). (Pubitemid 40981232)
58. Teramoto, K. et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J. Pharmacol. Sci. 106, 56-67 (2008). (Pubitemid 351159069)
59. Ruth, J.H. et al. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum. 54, 765-778 (2006).
60. Aslanian, A.M. & Charo, I.F. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114, 583-590 (2006). (Pubitemid 44199648)
61. Galkina, E. & Ley, K. Leukocyte influx in atherosclerosis. Curr. Drug Targets 8, 1239-1248 (2007). (Pubitemid 351144615)
62. Wuttge, D.M. et al. CXCL16/SR-PSOX is an interferon-γ-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 24, 750-755 (2004). (Pubitemid 38451615)
63. Jiang, X. et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J. Immunol. 175, 2051-2055 (2005). (Pubitemid 41113808)
64. Bouazzaoui, A. et al. Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes Immun. 10, 687-701 (2009).
65. Matsumura, K. et al. Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using 99mtechnetium-labeled anti-KL-6/MUC1 antibody. Radiat. Med. 26, 133-139 (2008). (Pubitemid 351652563)
66. Seidl, H. et al. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum. Pathol. 38, 768-780 (2007). (Pubitemid 46560803)
67. Gutwein, P. et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur. J. Cancer 45, 478-489 (2009).
68. Wang, J., Lu, Y., Koch, A.E., Zhang, J. & Taichman, R.S. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res. 68, 10367-10376 (2008).
69. Meijer, J. et al. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Cancer Res. 68, 4701-4708 (2008).
70. Liao, F. et al. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015-2023 (1997). (Pubitemid 27247087)
71. Limou, S. et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J. Infect. Dis. 202, 908-915 (2010).
72. Blaak, H. et al. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J. Virol. 79, 1686-1700 (2005). (Pubitemid 40459115)
73. Duggal, P. et al. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 4, 245-250 (2003). (Pubitemid 39562122)
74. Lanier, L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9, 495-502 (2008). (Pubitemid 351560518)
75. Lanier, L.L. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8, 259-268 (2008). (Pubitemid 351432802)
76. Scalzo, A.A., Manzur, M., Forbes, C.A., Brown, M.G. & Shellam, G.R. NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol. Cell Biol. 83, 144-149 (2005). (Pubitemid 40469321)
77. Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7, 517-523 (2006).
78. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001). (Pubitemid 32204059)
79. Yokoyama, W.M. & Kim, S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 214, 143-154 (2006). (Pubitemid 44707908)
80. Bjorkstrom, N.K. et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med 208, 13-21 (2011).
81. Martin, M.P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429-434 (2002). (Pubitemid 35154456)
82. Khakoo, S.I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874 (2004). (Pubitemid 39038423)
83. Reeves, R.K. et al. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115, 4439-4446 (2011).
84. Berahovich, R.D., Lai, N.L., Wei, Z., Lanier, L.L. & Schall, T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177, 7833-7840 (2006). (Pubitemid 44846299)
85. Cooper, M.D. & Alder, M.N. The evolution of adaptive immune systems. Cell 124, 815-822 (2006). (Pubitemid 43261454)
86. Vosshenrich, C.A. et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7, 1217-1224 (2006). (Pubitemid 44594318)
87. Fernandez-Busquets, X. & Burger, M.M. The main protein of the aggregation factor responsible for species-specific cell adhesion in the marine sponge Microciona prolifera is highly polymorphic. J. Biol. Chem. 272, 27839-27847 (1997). (Pubitemid 27473585)
88. Nicotra, M.L. et al. A hypervariable invertebrate allodeterminant. Curr. Biol. 19, 583-589 (2009).
89. Joly, E. Various hypotheses on MHC evolution suggested by the concerted evolution of CD94L and MHC class Ia molecules. Biol. Direct 1, 3 (2006).
90. Zucchetti, I. et al. ciCD94-1, an ascidian multipurpose C-type lectin-like receptor expressed in Ciona intestinalis hemocytes and larval neural structures. Differentiation 76, 267-282 (2008). (Pubitemid 351322683)
91. Flajnik, M.F. & Kasahara, M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat. Rev. Genet 11, 47-59 (2010).
92. Guo, P. et al. Dual nature of the adaptive immune system in lampreys. Nature 459, 796-801 (2009).
93. Uinuk-Ool, T.S. et al. Phylogeny of antigen-processing enzymes: cathepsins of a cephalochordate, an agnathan and a bony fish. Scand. J. Immunol. 58, 436-448 (2003). (Pubitemid 37215058)
94. Uinuk-ool, T.S. et al. Identification and characterization of a TAP-family gene in the lamprey. Immunogenetics 55, 38-48 (2003). (Pubitemid 36609819)
95. Tsutsui, S., Nakamura, O. & Watanabe, T. Lamprey (Lethenteron japonicum) IL-17 upregulated by LPS-stimulation in the skin cells. Immunogenetics 59, 873-882 (2007). (Pubitemid 350160027)
96. von Andrian, U.H. & Mempel, T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867-878 (2003). (Pubitemid 37411716)
97. Galkina, E. et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-γ production, and macrophage accumulation in the aortic wall. Circulation 116, 1801-1811 (2007). (Pubitemid 350287105)
98. Latta, M., Mohan, K. & Issekutz, T.B. CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis. Immunology 121, 555-564 (2007). (Pubitemid 47030093)
99. Diegelmann, J. et al. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Inflamm. Bowel Dis. 16, 1871-1881 (2010).
100. Matsumura, S. et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J. Immunol. 181, 3099-3107 (2008).
101. Liao, F. et al. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015-2023 (1997). (Pubitemid 27247087)
102. Heydtmann, M. et al. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J. Immunol. 174, 1055-1062 (2005). (Pubitemid 40094302)
103. Sato, T. et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J. Immunol. 174, 277-283 (2005). (Pubitemid 40007414)
104. Oh, S.T., Schramme, A., Tilgen, W., Gutwein, P. & Reichrath, J. Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinol. 1, 114-118 (2009).
105. Martini, G. et al. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. Clin. Immunol. 129, 268-276 (2008).
106. van der Voort, R. et al. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum. 52, 1381-1391 (2005). (Pubitemid 40663928)
107. Nanki, T. et al. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum. 52, 3004-3014 (2005). (Pubitemid 41447079)